All Articles

As household debt soars, Ramsey Solutions relaunches its EveryDollar app with AI tools and live coaching, aiming for a $20 billion annual impact.

Pan Global Resources has defined a major copper and gold resource in Spain, fueling the green energy transition and reviving a historic mining district.

Internet outages cost restaurants thousands. Bigleaf Networks' new 'Connected Kitchen' podcast explores how to build resilient networks and protect profits.

A new partnership aims to bring cutting-edge cancer trials to community clinics, accelerating drug development and expanding patient access to care.

858 Therapeutics' novel PARG inhibitor offers new hope for patients with a deadly, drug-resistant form of ovarian cancer, accelerating its path to approval.

Accenture's new investment in Profitmind's agentic AI platform signals a major shift for retail, promising to automate complex decisions and bridge the gap between data and action.

A new report challenges raid-focused tactics, using survivor stories to offer a blueprint for preventing exploitation in America's illicit massage industry.

The Spanish epigenetics leader will showcase its advanced CNS and oncology pipeline at key January conferences, seeking partners and investor validation.

The new x-hoppers mobile app bridges the gap between the frontline and back office, creating a unified, AI-powered communication network for all staff.

With a potential winter drill program at its Tharsis REE project and high-grade results at Big Mack, the company is advancing two key Canadian assets.

A new study on a compact, wireless robotic device could democratize access to precision knee surgery, thanks to pioneering work from a rural Missouri surgeon.

Collegium Pharmaceutical projects robust 2026 revenue fueled by its ADHD drug Jornay PM, savvy debt refinancing, and a proactive generic strategy.

Echo Water's new Echo One promises ultra-pure, hydrogen-rich water on demand. But is the cutting-edge science and technology worth the premium price tag?

Quantum PKI appoints Dr. Judy Gounden as CEO, signaling a strategic push for global growth, crypto-agility, and diverse leadership in digital trust.

With record growth and a fortified cash position, ElevateBio combines AI-driven discovery and industrial-scale manufacturing to power the gene therapy boom.

With a key FDA meeting set, Trevi Therapeutics pushes its drug Haduvio into late-stage trials, offering hope for millions with no approved treatments.

Keystone doubles down on AI advisory with Audax Private Equity's backing, spinning off its supply chain software unit into a new powerhouse, Keystone AI.

With nearly $30M in new funding, fintech firm Obita is building a blockchain-based network to tackle the high costs and delays of global B2B transactions.

The pet franchise doubled its stores in 3 years, achieving $150M in sales. Its rapid rise reflects a booming market and a new competitive landscape.

A new alliance between fintech innovators K1x and Juno promises to automate the most dreaded part of tax season, freeing CPAs from manual data entry.